6533b828fe1ef96bd1288c59

RESEARCH PRODUCT

No effect of length time bias on the genomic risk in ER+ HER2-stage I-IIA breast cancer (BC) patients according to diagnosis in a screening programme: An exploratory analysis

D. SalasJ.a. Perez FidalgoI. Gonzalez BarralloCristina HernandoJ.v. SorlíJudith Begoña RamírezOctavio BurguesA. LluchOlga Portolés

subject

Screening programmeOncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicineMedicineHematologyExploratory analysisLength time biasbusinessmedicine.diseasehttps://doi.org/10.1093/annonc/mdy297.034